NewsEvents

Your Yourlocation: Home > Clinical evaluation of tiotropium bromide(136310-93-5) combined with budesonide in the treatment of mild to moderate asthma

To observe the clinical efficacy of tiotropium bromide(136310-93-5) combined with glucocorticoid in patients with mild to moderate asthma. Methods: Sixty patients with mild to moderate asthma were randomly divided into two groups: tiotropium bromide(136310-93-5) group was given inhaled tiotropium bromide powder (18μg (160 / 4.5 μg, 2 times a day) in the inoculated budesonide dermotro powder (2 times a day) with budesonide dry powder (200 μg twice daily). The symptoms and signs and pulmonary function of the two groups were measured before and 8 weeks after treatment. Results: The symptoms and signs and pulmonary function of the patients in the tiotropium group and formoterol group were significantly improved at 8w after treatment, (P> 0.05). Conclusion: The addition of tiotropium bromide(136310-93-5) on the basis of inhaled corticosteroids can significantly improve the symptoms and lung function of patients with mild to moderate asthma.

Address: TEL:0531-82375879 Tiotropium Bromide
© Copyright(C)2014 JINAN DEXINJIA BIO & TECH CO., LTD All Rights Reserved